ChemicalBook > Product Catalog >API >Ipamorelin

Ipamorelin

Ipamorelin Structure
CAS No.
170851-70-4
Chemical Name:
Ipamorelin
Synonyms
IpaMorelin Acetate;Aib-His-D-2-Nal-D-Phe-Lys-NH2;Ipamoreli;IpoMarelin;IPAMORELIN;lpamorelin;NNC-26-0161;IPAMORELIN(5MG);IPAMORELIN(1MG);UNII-Y9M3S784Z6
CBNumber:
CB41117534
Molecular Formula:
C38H49N9O5
Molecular Weight:
711.85
MOL File:
170851-70-4.mol
MSDS File:
SDS
Modify Date:
2024/6/27 18:15:55

Ipamorelin Properties

Melting point 144-147°C
Boiling point 1185.5±65.0 °C(Predicted)
Density 1.263±0.06 g/cm3(Predicted)
storage temp. -20°C Freezer
solubility Acetonitrile (Slightly, Heated), Methanol (Very Slightly), Water (Slightly)
pka 13.04±0.46(Predicted)
form Solid
color White to Off-White
InChIKey NEHWBYHLYZGBNO-BVEPWEIPSA-N
SMILES C(N)(=O)[C@H](CCCCN)NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](CC1=CC=C2C(=C1)C=CC=C2)NC(=O)[C@H](CC1N=CNC=1)NC(=O)[C@](C)(C)N

Ipamorelin Chemical Properties,Uses,Production

Description

Ipamorelin (INN) (developmental code name NNC 26-0161) is a peptide selective agonist of the ghrelin/growth hormone secretagogue receptor (GHS) and a growth hormone secretagogue.It is a pentapeptide with the amino acid sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2 that was derived from GHRP-1.

Uses

Ipamorelin was originally developed by Novo Nordisk, and was investigated in phase II clinical trials by Helsinn Therapeutics for the treatment of postoperative ileus, but was discontinued due to lack of efficacy.Ipamorelin has been used by athletes as a performance enhancing drug.

benefits

Ipamorelin has a wide range of benefits for the human body such as: reduced body fat, increased collagen production, increased lean muscle mass, improved sleep, increased cell repair and regeneration, elevated IGF-1, increased bone mineral content, counteracted glucocorticoid catabolism, decreased appetite stimulation compared to GHRP-6, decreased release of cortisol, prolactin and aldosterone. Decreased release of cortisol, prolactin and aldosterone.

Side effects

Ipamorelin is generally considered safe and well tolerated, with common side effects including dizziness, headache, nausea, diarrhoea and flushing. Allergic or serious adverse reactions are rare.

Ipamorelin Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 194)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Wuhan Cell Pharmaceutical Co., Ltd +86-13129979210 +86-13129979210 China 376 58 Inquiry
Changzhou Xuanming Pharmaceutical Technology Co., Ltd. +8618068519287 China 833 58 Inquiry
Nantong Guangyuan Chemicl Co,Ltd +undefined17712220823 China 616 58 Inquiry
Apeloa production Co.,Limited +8619933239880 China 853 58 Inquiry
Shanghai Affida new material science and technology center +undefined15081010295 China 114 58 Inquiry
Hangzhou Hyper Chemicals Limited +86-0086-57187702781 +8613675893055 China 200 58 Inquiry
Hebei Mojin Biotechnology Co., Ltd +86 13288715578 +8613288715578 China 12459 58 Inquiry
Hebei Yime New Material Technology Co., Ltd. +86-66697723 +86-17703311139 China 563 58 Inquiry
Zhejiang Hangyu API Co., Ltd +8617531972939 China 2944 58 Inquiry
Xiamen Wonderful Bio Technology Co., Ltd. +8613043004613 China 305 58 Inquiry

Related articles

  • The introduction of Ipamorelin
  • Ipamorelin is a new and potent synthetic pentapeptide with distinct and specific growth hormone (GH)--releasing properties.
  • Jun 17,2024
IpoMarelin IPAMORELIN(1MG) IPAMORELIN(5MG) 2-Methylalanyl-L-histidyl-3-(2-naphthyl)-D-alanyl-D-phenylalanyl-L-lysinamide L-Lysinamide,2-methylalanyl-L-histidyl-3-(2-naphthalenyl)-D-alanyl-D-phenylalanyl- NNC-26-0161 ipamorelin peptide powder Peptides 5mg ipamorelin UNII-Y9M3S784Z6 (2S)-6-amino-2-[[(2R)-2-[[(2R)-2-[[(2S)-2-[(2-amino-2-methylpropanoyl)amino]-3-(4H-imidazol-4-yl)propanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]-3-phenylpropanoyl]amino]hexanamide Quality and Shipping Guaranteed Peptides Peptide Ipamorelin 2mg/Vial Ipamorelin USP/EP/BP Ipamorelin (NNC26-0161) IpaMorelin Acetate Aib-His-D-2-Nal-D-Phe-Lys-NH2 IPAMORELIN Ipamoreli lpamorelin Ipamorelin 2 Pivalic acid 170851-70-4 C38H49N9O5 Peptides 170851-70-4